Many communications, such as examination reports, currently issued by the European Patent Office (EPO) that set a due date for…
Read More
Many communications, such as examination reports, currently issued by the European Patent Office (EPO) that set a due date for…
Read MoreThe EPO’s Enlarged Board of Appeal has published its much-awaited decision on G 1/22 and G 2/22 regarding the validity…
Read MoreSince going live on 1 June 2023, the new Unified Patent Court (UPC) has been quick off the mark, with…
Read MoreIn today’s globalised world, counterfeit pharmaceuticals have emerged as a silent epidemic, endangering the health and lives of millions. The…
Read MoreThe UK Intellectual Property Office (UK IPO) is the first national intellectual property office to upgrade its in-house search facilities…
Read MoreSince the start of the COVID-19 pandemic there have been remarkable research and innovation efforts to fight the SARS-COV-2 virus….
Read MoreWhen the UK left the EU with effect from 1 January 2021, the UK Intellectual Property Office (UK IPO) set…
Read MoreMotor Neurone Disease (MND) is a debilitating neurodegenerative disease that affects the brain and spinal cord, leading to the death…
Read MoreUnder the current practice of the China National Intellectual Property Administration (CNIPA), the suspension of a trade mark application is…
Read MoreWith the Unified Patent Court (UPC) having opened its doors on 1 June 2023, heralding a new era for patent…
Read MoreThe European Patent Office’s (EPO) Enlarged Board of Appeal’s decision in G2/21 primarily relates to when data that only becomes…
Read MoreA resignation letter has been submitted. The Director, who joined the business in its infancy and has been part of…
Read More